发明授权
US06562335B1 NK-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
失效
用于预防基因治疗神经源性炎症的NK-1受体拮抗剂
- 专利标题： NK-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
- 专利标题（中）： 用于预防基因治疗神经源性炎症的NK-1受体拮抗剂
-
申请号： US09077045申请日： 1998-05-18
-
公开(公告)号： US06562335B1公开(公告)日： 2003-05-13
- 发明人: Giovanni Piedimonte , Hans J. Hess , John A. Lowe, III
- 申请人： Giovanni Piedimonte , Hans J. Hess , John A. Lowe, III
- 主分类号： A61K4800
- IPC分类号： A61K4800
摘要：
The present invention relates to a method for inhibiting a neurogenic inflammation caused or potentiated by an administration of viral vectors in gene therapy by administering to said mammal an antagonist that binds to a NK-1 receptor in an amount that is effective to inhibit said neurogenic inflammation.
信息查询
